Thomas Sciascia

Companies

• Trevi Therapeutics, Inc.Chief Medical Officer May 7, 2019 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TTTrevi Therapeutics, Inc. TRVI221,373 shares²$2.7M at $12.14Mar 25, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 25, 2025Sold 2,631 shares at $6.60 of Trevi Therapeutics, Inc.²
• Mar 25, 2025Exercised options 2,631 shares at $1.43 of Trevi Therapeutics, Inc.²
• Aug 19, 2024Sold 16,496 shares at $2.96 of Trevi Therapeutics, Inc.³
• Aug 19, 2024Exercised options 16,496 shares at $1.43 of Trevi Therapeutics, Inc.³
• Aug 16, 2024Sold 18,660 shares at $2.76 of Trevi Therapeutics, Inc.⁴
• Aug 16, 2024Exercised options 18,660 shares at $1.43 of Trevi Therapeutics, Inc.⁴
• Aug 15, 2024Sold 12,745 shares at $2.79 of Trevi Therapeutics, Inc.⁴
• Aug 15, 2024Exercised options 12,745 shares at $1.43 of Trevi Therapeutics, Inc.⁴
• Aug 14, 2024Sold 100 shares at $2.75 of Trevi Therapeutics, Inc.⁴
• Aug 14, 2024Exercised options 100 shares at $1.43 of Trevi Therapeutics, Inc.⁴
• May 29, 2024Sold 53,368 shares at $2.55 of Trevi Therapeutics, Inc.⁵
• May 29, 2024Exercised options 59,354 shares at $2.19 of Trevi Therapeutics, Inc.⁵